Preclinical News and Research

RSS
Spinifex initiates EMA401 Phase 2 trial in postherpetic neuralgia

Spinifex initiates EMA401 Phase 2 trial in postherpetic neuralgia

USPTO issues notice of allowance to Cenestra Health's omega-3 fatty acid formulations

USPTO issues notice of allowance to Cenestra Health's omega-3 fatty acid formulations

BARDA awards Vaxin $21.7M contract to accelerate development of novel anthrax vaccine

BARDA awards Vaxin $21.7M contract to accelerate development of novel anthrax vaccine

Nanion’s automated patch clamp platforms show unparalleled results using stem cell derived cardiomyocytes

Nanion’s automated patch clamp platforms show unparalleled results using stem cell derived cardiomyocytes

Policies needed to prepare individuals, society for earlier diagnosis and high risk of Alzheimer's

Policies needed to prepare individuals, society for earlier diagnosis and high risk of Alzheimer's

Anavex announces ANAVEX pre-clinical data on Alzheimer's disease

Anavex announces ANAVEX pre-clinical data on Alzheimer's disease

Estrogen therapy can reverse progression of pulmonary hypertension

Estrogen therapy can reverse progression of pulmonary hypertension

Potential new treatment for fragile X syndrome

Potential new treatment for fragile X syndrome

Polyplus-transfection appoints ten additional biologists and chemists to support multiple pre-clinical studies

Polyplus-transfection appoints ten additional biologists and chemists to support multiple pre-clinical studies

Hengrui, Shanghai ChemPartner enter strategic development partnership for monoclonal antibodies

Hengrui, Shanghai ChemPartner enter strategic development partnership for monoclonal antibodies

VBI Vaccines completes acquisition of Epixis

VBI Vaccines completes acquisition of Epixis

Positive results from PROLOR Biotech's Factor VIIa-CTP preclinical study on hemophilia

Positive results from PROLOR Biotech's Factor VIIa-CTP preclinical study on hemophilia

DiscoveryBioMed receives NIDDK grant for Cystic Fibrosis Corrector Ligand Drug Discovery program

DiscoveryBioMed receives NIDDK grant for Cystic Fibrosis Corrector Ligand Drug Discovery program

Viamet commences VT-1161 Phase 1 clinical study to treat fungal infections

Viamet commences VT-1161 Phase 1 clinical study to treat fungal infections

Researchers may have solved 100-year-old puzzle to safely open and close the blood-brain barrier

Researchers may have solved 100-year-old puzzle to safely open and close the blood-brain barrier

Nanobiotix starts clinical trial of new cancer treatment for soft tissue sarcoma

Nanobiotix starts clinical trial of new cancer treatment for soft tissue sarcoma

OBT, Seattle Genetics form strategic collaboration to discover novel ADCs for cancer

OBT, Seattle Genetics form strategic collaboration to discover novel ADCs for cancer

AM-Pharma announces €29.2m series D round of financing

AM-Pharma announces €29.2m series D round of financing

Positive data from NovaDigm's NDV-3 vaccine program to be presented at ICAAC conference

Positive data from NovaDigm's NDV-3 vaccine program to be presented at ICAAC conference

Hawthorn, CoPlex Therapeutics sign licensing deal to develop and commercialize hawAD14 for Alzheimer's

Hawthorn, CoPlex Therapeutics sign licensing deal to develop and commercialize hawAD14 for Alzheimer's

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.